Assesses healthcare resource utilization and treatment persistence in patients with Lennox-Gastaut Syndrome receiving fenfluramine, suggesting implications for care management.
To assess healthcare resource utilization (HCRU), antiseizure medication (ASM) claims, and treatment persistence in patients with LGS receiving fenfluramine from a large US claims database.
No takes yet. Share an insight, caveat, or question.
Kerr et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: